These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 34939977)

  • 21. [The Role of FGF21 in Regulating Lipid and Glucose Metabolism].
    Yang WQ; Ling WH
    Sheng Li Ke Xue Jin Zhan; 2016 Aug; 47(4):260-4. PubMed ID: 29888896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation.
    Zhang C; Shao M; Yang H; Chen L; Yu L; Cong W; Tian H; Zhang F; Cheng P; Jin L; Tan Y; Li X; Cai L; Lu X
    PLoS One; 2013; 8(12):e82275. PubMed ID: 24349242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction.
    Ma Y; Kuang Y; Bo W; Liang Q; Zhu W; Cai M; Tian Z
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.
    Yan X; Chen J; Zhang C; Zhou S; Zhang Z; Chen J; Feng W; Li X; Tan Y
    J Cell Mol Med; 2015 Jul; 19(7):1557-68. PubMed ID: 25823710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease.
    Kralisch S; Fasshauer M
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):354-9. PubMed ID: 21505329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network.
    Li S; Zou T; Chen J; Li J; You J
    Genes Dis; 2024 May; 11(3):101064. PubMed ID: 38292170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis.
    Lakhani I; Gong M; Wong WT; Bazoukis G; Lampropoulos K; Wong SH; Wu WKK; Wong MCS; Ong KL; Liu T; Tse G;
    Metabolism; 2018 Jun; 83():11-17. PubMed ID: 29410351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses.
    Salminen A; Kaarniranta K; Kauppinen A
    Ageing Res Rev; 2017 Aug; 37():79-93. PubMed ID: 28552719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role of FGF21 in diabetic kidney disease: from energy metabolism to innate immunity.
    Liang Y; Chen Q; Chang Y; Han J; Yan J; Chen Z; Zhou J
    Front Immunol; 2024; 15():1333429. PubMed ID: 38312833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-Level Serum Fibroblast Growth Factor 21 Concentration Is Closely Associated With an Increased Risk of Cardiovascular Diseases: A Systematic Review and Meta-Analysis.
    Zhang Y; Yan J; Yang N; Qian Z; Nie H; Yang Z; Yan D; Wei X; Ruan L; Huang Y; Zhang C; Zhang L
    Front Cardiovasc Med; 2021; 8():705273. PubMed ID: 34513950
    [No Abstract]   [Full Text] [Related]  

  • 32. The roles of FGF21 in atherosclerosis pathogenesis.
    Tabari FS; Karimian A; Parsian H; Rameshknia V; Mahmoodpour A; Majidinia M; Maniati M; Yousefi B
    Rev Endocr Metab Disord; 2019 Mar; 20(1):103-114. PubMed ID: 30879171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor 21 as a potential master regulator in metabolic disorders.
    Velingkar A; Vuree S; Prabhakar PK; Kalashikam RR; Banerjee A; Kondeti S
    Am J Physiol Endocrinol Metab; 2023 May; 324(5):E409-E424. PubMed ID: 36629821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
    Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of energy balance by fibroblast growth factor 21.
    Cuevas-Ramos D; Aguilar-Salinas CA
    Horm Mol Biol Clin Investig; 2016 Jun; 30(1):. PubMed ID: 27318658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis.
    Ong KL; Campbell S; Wu BJ; McClelland RL; Kokkinos J; Szklo M; Polak JF; Allison MA; Rye KA
    Atherosclerosis; 2019 Aug; 287():46-53. PubMed ID: 31212234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease.
    Kohara M; Masuda T; Shiizaki K; Akimoto T; Watanabe Y; Honma S; Sekiguchi C; Miyazawa Y; Kusano E; Kanda Y; Asano Y; Kuro-O M; Nagata D
    PLoS One; 2017; 12(6):e0178971. PubMed ID: 28582462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGF21 and Chronic Kidney Disease.
    Salgado JV; Goes MA; Salgado Filho N
    Metabolism; 2021 May; 118():154738. PubMed ID: 33617873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.
    Lee CH; Woo YC; Chow WS; Cheung CYY; Fong CHY; Yuen MMA; Xu A; Tse HF; Lam KSL
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 21 protects against high glucose induced cellular damage and dysfunction of endothelial nitric-oxide synthase in endothelial cells.
    Wang XM; Song SS; Xiao H; Gao P; Li XJ; Si LY
    Cell Physiol Biochem; 2014; 34(3):658-71. PubMed ID: 25170746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.